Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Fred Hutch Cancer Center

InstitutionResearch output, impact & collaborations

Fred Hutch Cancer Center is a research organisation in Seattle, US. OpenAlex records 57,528 works and 11,331,394 citations for it. 8,260 researchers list it as their most recent affiliation.

57,528
Works
11,331,394
Citations
8,260
Researchers
60
Avg h-index

How has Fred Hutch Cancer Center's publication output changed over time?

ScholarIQpublication output · 1996–2020

Output grew0% over the shown period — from 1 works in 1996 to 1 in 2020.

1
2
1
1
1
1
2
1
1
1
1996200120042006201120132016201720182020

Who are the most-cited researchers behind Fred Hutch Cancer Center?

ScholarIQtop researchers by citations
1
Qian Wu · CAR-T cell therapy research
241 works4,734 citations
2
Jonathan Cohen · Total Knee Arthroplasty Outcomes
20 works459 citations

What are the most-cited papers on Fred Hutch Cancer Center?

ScholarIQmost cited works
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
Jonathan E. Rosenberg, Jean Hoffman‐Censits, Tom Powles, Michiel S. van der Heijden, Arjun Vasant Balar, Andrea Necchi, Nancy A. Dawson, Peter H. O’Donnell, Ani Sarkis Balmanoukian, Yohann Loriot, Sandy Srinivas, Margitta Retz, Petros Grivas, Richard W. Joseph, Matthew D. Galsky, Mark T. Fleming, Daniel P. Petrylak, José Luis Perez‐Gracia, Howard A. Burris, Daniel Castellano, Christina Canil, Joaquim Bellmunt, Dean F. Bajorin, Dorothee Nickles, Richard Bourgon, Garrett M. Frampton, Na Cui, Sanjeev Mariathasan, Oyewale O. Abidoye, Gregg Fine, Robert Dreicer
The Lancet. 20163,735 Citations
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
Julie R. Brahmer, Christina Lacchetti, Bryan J. Schneider, Michael B. Atkins, Kelly Brassil, Jeffrey M. Caterino, Ian Chau, Marc S. Ernstoff, Jennifer M. Gardner, Pamela Ginex, Sigrun Hallmeyer, Jennifer Holter Chakrabarty, Natasha B. Leighl, Jennifer S. Mammen, David F. McDermott, Aung Naing, Loretta J. Nastoupil, Tanyanika Phillips, Laura Porter, Igor Puzanov, Cristina Reichner, Bianca Santomasso, Carole Seigel, Alexander I. Spira, María E. Suarez‐Almazor, Yinghong Wang, Jeffrey S. Weber, Jedd D. Wolchok, John A. Thompson
Journal of Clinical Oncology. 20183,734 CitationsOPEN ACCESS
Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer
Daniel P. Petrylak, Catherine M. Tangen, Maha Hussain, Primo N. Lara, Jeffrey A. Jones, Mary Ellen Taplin, Patrick A. Burch, Donna L. Berry, Carol M. Moinpour, Manish Kohli, Mitchell C. Benson, Eric J. Small, Derek Raghavan, E. David Crawford
New England Journal of Medicine. 20043,691 CitationsOPEN ACCESS
Effects of a Combination of Beta Carotene and Vitamin A on Lung Cancer and Cardiovascular Disease
Gilbert S. Omenn, Gary E. Goodman, Mark Thornquist, John R. Balmes, Mark R. Cullen, Andrew G. Glass, James P. Keogh, Frank L. Meyskens, Barbara Valanis, James H. Williams, Scott Barnhart, Samuel P. Hammar
New England Journal of Medicine. 19963,650 CitationsOPEN ACCESS
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
Joaquim Bellmunt, Ronald de Wit, David J. Vaughn, Yves Fradet, Jae‐Lyun Lee, Lawrence Fong, Nicholas J. Vogelzang, Miguel Ángel Climent, Daniel P. Petrylak, Toni K. Choueiri, Andrea Necchi, Winald R. Gerritsen, Howard Gurney, David I. Quinn, Stéphane Culine, Cora N. Sternberg, Yabing Mai, Christian Poehlein, Rodolfo F. Perini, Dean F. Bajorin
New England Journal of Medicine. 20173,424 CitationsOPEN ACCESS

Who collaborates most closely around Fred Hutch Cancer Center?

ScholarIQco-authorship network
United States
100%

How much of the research on Fred Hutch Cancer Center is open access?

ScholarIQopen access share
75%OPEN ACCESS
Gold
0%
Green
33%
Hybrid
8%
Bronze
33%
Closed
25%

Related on ScholarIQ

Hematopoietic Stem Cell Transplantation
Top Topic
Acute Myeloid Leukemia Research
Top Topic
CAR-T cell therapy research
Top Topic
Immune Cell Function and Interaction
Top Topic
HIV Research and Treatment
Top Topic
T-cell and B-cell Immunology
Top Topic
470M+ articles · free account